Nicotinic receptor-mediated protection against β-amyloid neurotoxicity

Biological Psychiatry

Volumn 49, Issue 3, 2001, Pages 233-239

  Shimohama, Shun ^a   Kihara, Takeshi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

amyloid; Alzheimer's disease; Glutamate; Nicotine; Nicotinic receptor; Protection

Indexed keywords

ALPHA BUNGAROTOXIN; AMYLOID BETA PROTEIN; CYTISINE; DIHYDRO BETA ERYTHROIDINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN BCL 2; PROTEIN BCL X; RECEPTOR SUBUNIT; THREONINE PROTEINASE;

ALZHEIMER DISEASE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; DISEASE COURSE; DRUG ACTIVATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HYPOTHESIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; STIMULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; CELL DEATH; HUMANS; NICOTINE; RECEPTORS, NICOTINIC;

EID: 0035251752     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)01100-8     Document Type: Review

References (62)

1. Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity
2. Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: A combined fluorescent tracer and acetylcholinesterase analysis
3. Nicotine treatment counteracts perinatal asphyxia-induced changes in mesostriatal/limbic dopamine systems and in motor behaviour in the four-week old male rat
4. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage
5. Aspartate neurotoxicity on cultured cortical neurons
6. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production
7. 125I]-alpha-bungarotoxin
8. Nicotinic receptor function: New perspectives from knockout mice
9. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
10. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
11. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line
12. Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial dimesencephalic hemitransection
13. Distinct patterns of neuronal loss and Alzheimer's disease lesion distribution in elderly individuals older than 90 years
14. Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cell
15. +-dependent glutamate uptake in rat hippocampal astrocyte cultures
16. Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture
17. Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells
18. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus
19. Protective effects of chronic nicotine treatment on lesioned dopamine neurons in the male rat
20. Chronic nicotine treatment counteracts the decrease in extracellular neostriatal dopamine induced by unilateral transection at the mesodiencephalic junction in rats: A microdialysis study
21. Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression
22. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease
23. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via alpha7-neuronal receptors and neuronal CNS receptors
24. Neuroprotective effect of nicotinic agonists via PI3 kinase cascade against glutamate cytotoxicity enhanced by beta amyloid
25. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity
26. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity
27. Nicotinic systems and cognitive function
28. Alpha7 nicotinic receptor-mediated protection against ethanol-induced oxidative stress and cytotoxicity in PC12 cells
29. Characterization of the neuroprotective and toxic effects of alpha7 nicotinic receptor activation in PC12 cells
30. Neuronal nicotinic receptor subtypes
31. Noncompetitive agonism at nicotinic acetylcholine receptors; functional significance for CNS signal transduction
32. Glutamate dysfunction in Alzheimer's disease: An hypothesis
33. Nicotine protects cultured striatal neurons against N-methyl-D-aspartate receptor-mediated neurotoxicity
34. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons
35. Neurotransmitters in the regulation of neuronal cytoarchitecture
36. Acetylcholine potentiates glutamate-induced neurodegeneration in cultured hippocampal neurons
37. A sulfated proteoglycan aggregation factor mediates amyloid-beta peptide fibril formation and neurotoxicity
38. Excitatory amino acid neurotoxicity and neurodegenerative disease
39. Activation of alpha7 nicotinic acetylcholine receptor promotes survival of spinal cord motoneurons
40. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkey
41. Analysis of 3-(4-hydroxy, 2-methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors
42. 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner
43. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation
44. GTS-21, a nicotinic agonist, protects against neocortical neuronal cell loss induced by the nucleus basalis magnocellularis lesion in rats
45. Protective effect of GTS-21, a novel nicotinic receptor agonist, on delayed neuronal death induced by ischemia in gerbils
46. Age-related effects of the nicotinic antagonist mecamylamine on cognition and behaviour
47. NMDA antagonist neurotoxicity: Mechanism and prevention
48. Increased regional cerebral blood glucose metabolism and sematic memory performance in Alzheimer's disease: A pilot double blind transdermal nicotine positron emission tomography study
49. The substantia innominata in Alzheimer's disease: A histochemical and biochemical study of cholinergic marker enzymes
50. Nicotine-induced protection against glutamate cytotoxicity. Nicotinic cholinergic receptor-mediated inhibition of nitric oxide formation
51. Nicotinic alpha 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage
52. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia
53. 3H]GABA uptake in nucleus basalis lesioned rats
54. Chronic nicotine treatment prevents neuronal loss in neocortex resulting from nucleus basalis lesions in young adult and aged rats
55. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue
56. Smoking, nicotine and human performance
57. Nicotinic receptors and neurodegenerative dementing diseases: Basic research and clinical implications
58. Alzheimer's disease: Evidence for a selective loss of cholinergic neurons in the nucleus basalis
59. Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides
60. Nicotine modulates the neurotoxic effect of beta-amyloid protein (25-35) in hippocampal cultures
61. BCL-2 blocks glutamate toxicity in neural cell lines
62. Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors